Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a ...

as they bring Eli Lilly's drug one step closer to becoming a new, needle-free alternative for weight loss and diabetes. "This could join a growing toolbox of medications for obesity, and it ...

Eli Lilly (LLY) Leads India’s Weight-Loss Drug Race with Mounjaro Hims & Hers’ Weight-Loss Empire Hits a Gut-Wrenching Barrier 3 Best Growth Stocks to Buy Now, 3/19/2025, According to Analysts ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover advantage in a market with a large obese population. This move positions ...

US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).

as they bring Eli Lilly's drug one step closer to becoming a new, needle-free alternative for weight loss and diabetes. Get top local stories in Southern California delivered to you every morning.

Eli Lilly (LLY) launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk (NVO) for a much-awaited entry into the world’s most populous ...

HYDERABAD (Reuters) -Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most ...